2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Imaging, Gene Editing, Treatment Considerations, Supportive Care, Biological Therapies, Transfusion, Gene Therapy, Workforce, Adverse Events, Artificial Intelligence (AI), Natural Language Processing, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Value, Diseases, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Thalassemia, Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Survivorship, Study Population, Human, Adult, Pediatric
PAPER

2594 Project ECHO as a strategy to improve access to evidence-based thalassemia care: The central region thalassemia collaborative (CRTC)

Sarah E Null, MPH, Stephanie Fritch Lilla, MD2, Jennifer Tran, MD3, Kalindi Y Narine, MD4, Allison Remiker, MD5, Lisa Shook, PhD6, Stephanie Matthies, APRN, RN7, Hannah Wyler, APRN, RN8, Nicole Hart, BSN, RN9, Alexis A. Thompson, MD MPH10, Sherif M. Badawy, MD, MS, MBA11
1 Ann and Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
2 Children's Minnesota, Minneapolis, Minnesota, United States
3 Texas Children Hospital, Houston, Texas, United States
4 Texas Children Hospital, Houston, Texas, United States
5 Children's Wisconsin, Milwaukee, Wisconsin, United States
6 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
7 Ann and Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
8 Ann and Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
9 Children's Minnesota, Minneapolis, Minnesota, United States
10 Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
11 Ann and Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Introduction: Patients with thalassemia and their families face barriers in accessing high-quality, evidence-based treatment. Primary care providers and general hematologists oncologists have limited experience providing care to patients with thalassemia as they see them infrequently at their centers; often following only a few patients. Most thalassemia experts are at large academic medical centers in major US cities. This results in potentially suboptimal and inconsistent management of patients with thalassemia. Through the funding support from the Health Resources & Services Administration (HRSA), the Central Region Thalassemia Collaborative (CRTC) was established in 2021 to improve access to evidence-informed care for patients with thalassemia across 16 states in the Midwest of the United States. Applying the Project ECHO (Extension for Community Healthcare Outcomes) tele-mentoring model, CRTC Tele-ECHO Series launched in 2022 to educate healthcare providers on thalassemia management and evidence-based treatment guidelines. The objectives of the CRTC Tele-ECHO program are: (1) to provide education on evidence-based guidelines for thalassemia treatment to healthcare providers in the Midwest region, and (2) to increase their utilization of evidence-based guidelines to treat individuals with thalassemia.  

Methods: The CRTC Tele-ECHO Program delivers monthly 1-hour webinars (1st Thursdays of every month) consisting of thalassemia expert-led didactics and discussion of de-identified unique cases. Participants join the webinars virtually via communication platforms (i.e., Zoom or Teams). Program reach and impact were assessed using attendance records, post-session surveys, and annual provider survey responses that evaluated participants’ satisfaction, knowledge and awareness gained, and self-efficacy in managing patients with thalassemia. 

Results: The CRTC Tele-ECHO Program engaged 173 unique participants from 6 countries (Canada, Greece, Italy, Lebanon, South Africa, and the United States) over 37 webinars. In the United States, healthcare professionals from 21 states participated in the program. Across all countries, 63 institutions were reached, and the majority were from University Hospital Systems. Participants included pediatric hematologists (36%), nurse practitioners (12%), nurses and nurse specialists (12%), hematology/oncology fellows (9%), adult hematologists (6%), physician scientists (5%), and other health professionals (9%).  

Overall, we have seen a steady upward trend in CRTC Tele-ECHO attendance over time with an average attendance of 23 participants per session (range 11-43 participants). The webinars focused on a variety of topics, including Transfusion Medicine & Clinical Management (27%), Emerging & Curative Therapies (27%), Iron Overload & Disease Complications (22%), Diagnostics (16%), and Quality of Life (8%).  

In total, there were 181 responses to the post-evaluation survey across 37 sessions. Almost all participants indicated that they would recommend the program to a colleague (98%) and rated the sessions as “good” or “excellent” (99%), reflecting a very high satisfaction with the webinars. Furthermore, participants overwhelmingly reported improved knowledge of evidence-based thalassemia care (97%), enhanced clinical ability in decision making (94%), especially from case discussions, and intent to apply learned practices in their practice (92%). Most participants (98%) agreed that presenters demonstrated mastery of the topics and that the sessions were free of commercial bias  

In the annual provider survey, the CRTC Tele-ECHO program saw a remarkable increase in the number of healthcare providers who reported an increased knowledge of evidence-based treatment guidelines for thalassemia from Year 1 (n=15) to Year 5 (n=116). Since its launch, the CRTC Tele-ECHO program has awarded 844 continuing education credits, such as CME. 

Conclusions: The CRTC Tele-ECHO Program demonstrated a strong reach and a positive impact in expanding provider knowledge and confidence in implementing evidence-based guidelines for thalassemia care across the Central Region of the United States. CRTC Tele-ECHO program participants were highly satisfied with the sessions’ content, format and clinical relevance in thalassemia. Our data suggest that the CRTC Tele-ECHO Program has improved access to high-quality, evidence-based management for patients with thalassemia across the Midwest Region.  

Sarah E Null, MPH: No relevant conflicts of interest to declare.